论文部分内容阅读
目前国内外对肾上腺皮质激素治疗重型肝炎的利弊存在一定的争议.但 Muto et al 报告,1993年从日本各大中心收集的数百例暴发性病毒性肝炎(相当于我国的急性重型肝炎),用激素疗法者占52.7%～61.2%.我们应用激素短程疗法治疗病毒性重型肝炎亦取得了一定的疗效,为进一步探讨其疗效机制,我们于1998-03/1999-06,对13例激素治疗的病毒性重型肝炎患者血清 TNFα和 sIL-2R 水平进行了观察.
However, Muto et al report that hundreds of cases of fulminant viral hepatitis (equivalent to acute severe hepatitis) collected from major centers in Japan in 1993 were controversial, Hormone therapy accounted for 52.7% ~ 61.2% .He application of hormone short-course therapy for viral severe hepatitis has also made some curative effect, in order to further explore the mechanism of its efficacy, we in 1998-03 / 1999-06, 13 cases of hormone therapy Of patients with viral hepatitis and serum TNFα and sIL-2R levels were observed.